Search Results - "Grima, Michael"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells by Lloyd, Mitchell M, Grima, Michael A, Rayner, Benjamin S, Hadfield, Katrina A, Davies, Michael J, Hawkins, Clare L

    Published in Free radical biology & medicine (01-12-2013)
    “…In the immune response, hypohalous acids are generated by activated leukocytes via the release of myeloperoxidase and the formation of H₂O₂. Although these…”
    Get full text
    Journal Article
  2. 2

    Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection by Flórido, Manuela, Grima, Michael A, Gillis, Caitlin M, Xia, Yingju, Turner, Stephen J, Triccas, James A, Stambas, John, Britton, Warwick J

    Published in The Journal of immunology (1950) (01-07-2013)
    “…Individuals infected with mycobacteria are likely to experience episodes of concurrent infections with unrelated respiratory pathogens, including the seasonal…”
    Get full text
    Journal Article
  3. 3

    In vitro assessment of the potential for abuse via the intravenous route of oxycodone DETERx® microspheres by Fleming, Alison B, Scungio, Todd A, Grima, Michael P, Mayock, Stephen P

    Published in Journal of opioid management (01-01-2016)
    “…Abuse of prescription analgesics is a well-recognized problem, with nearly 2 million people aged 12 years or older initiating nonmedical use of pain relievers…”
    Get more information
    Journal Article
  4. 4

    Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation by Kopecky, Ernest A, Fleming, Alison B, Noonan, Patrick K, Varanasi, Ravi K, Grima, Michael, Saim, Said, Mayock, Stephen P

    Published in Journal of opioid management (01-07-2014)
    “…In vitro: To assess the effect of common crushing techniques on particle size reduction (PSR) and in vitro drug-release kinetics of oxycodone DETERx® (herein…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD) by Fleming, Alison B., Carlson, Douglas R., Varanasi, Ravi K., Grima, Michael, Mayock, Stephen P., Saim, Said, Kopecky, Ernest A.

    Published in Pain practice (01-03-2016)
    “…Background Patients who have chronic pain with dysphagia (difficulty swallowing) (CPD) often have difficulty taking oral medication and, as such, alter their…”
    Get full text
    Journal Article
  7. 7

    Consumer perception of community pharmacist extended professional services by Vella, Maria, Grima, Michael, Wirth, Francesca, Attard Pizzuto, Maresca, Sammut Bartolo, Nicolette, Vella, Janis, Azzopardi, Lilian M.

    “…Objective To assess the perception of Maltese consumers regarding extended professional services for community pharmacists. Methods The self‐administered…”
    Get full text
    Journal Article
  8. 8